Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Brigatinib Monotherapy in Children with R/R ALK+ ALCL, IMT, or Other Solid Tumors: Updated Results from the Brigaped (ITCC-098) Phase 1 Dose-Escalation Study

Blood (2024) 144 (Supplement 1): 3108.

https://doi.org/10.1182/blood-2024-200077

Published: 2024

Journal Articles

Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors: Results from the AML SCT-BFM 2007 Trial

Blood (2024) 144 (Supplement 1): 3563.

https://doi.org/10.1182/blood-2024-200574

Published: 2024

Journal Articles

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Blood (2024) 144 (13): 1412–1417.

https://doi.org/10.1182/blood.2024025307

Published: 2024

Includes: Supplemental data

Journal Articles

Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance

Blood (2021) 137 (17): 2347–2359.

https://doi.org/10.1182/blood.2020005381

Published: 2021

Includes: Supplemental data

Journal Articles

IL10RA modulates crizotinib sensitivity in NPM1-ALK + anaplastic large cell lymphoma

Blood (2020) 136 (14): 1657–1669.

https://doi.org/10.1182/blood.2019003793

Published: 2020

Includes: Supplemental data

Journal Articles

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Wilhelm Woessmann, Martin Zimmermann, Andrea Meinhardt, Stephanie Müller, Holger Hauch, Fabian Knörr, Ilske Oschlies, Wolfram Klapper, Felix Niggli, Edita Kabickova, Andishe Attarbaschi, Alfred Reiter, Birgit Burkhardt

Blood (2020) 135 (14): 1124–1132.

https://doi.org/10.1182/blood.2019003591

Published: 2020

Includes: Supplemental data

Journal Articles

Imatinib +/- Brentuximab Vedotin Induces Sustained Complete Remission in Chemotherapy-Resistant Anaplastic Large Cell Lymphoma Expressing PDGFR

Philipp Bernhard Staber, MD PhD, Christoph Kornauth, Ines Garces de los Fayos Alonso, Wilhelm Woessmann, MD, Wolfram Klapper, Sabine Lagger, Ana-Iris Schiefer, Cathrin Skrabs, Olaf Merkel, PhD, Marius E Mayerhoefer, Richard Greil, MD, Ingrid Simonitsch-Klupp, MD, Lukas Kenner, MD, Ulrich Jaeger, MD

Blood (2019) 134 (Supplement_1): 4037.

https://doi.org/10.1182/blood-2019-129955

Published: 2019

Journal Articles

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

Olga Moser, MD, Arnaud Dalissier, PhD, Eric Beohou, Wilhelm Woessmann, MD, Birgit Burkhardt, MD PhD, Karin Mellgren, MD PhD, Peter Bader, MD PhD, Andre Manfred Willasch, MD, Udo Kontny, MD

Blood (2018) 132 (Supplement 1): 5787.

https://doi.org/10.1182/blood-2018-99-116809

Published: 2018

Journal Articles

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

Blood (2017) 130 (Supplement 1): 599.

https://doi.org/10.1182/blood.V130.Suppl_1.599.599

Published: 2017

Journal Articles

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Blood (2016) 127 (25): 3281–3290.

https://doi.org/10.1182/blood-2015-12-684498

Published: 2016

Includes: Supplemental data

Journal Articles

Exchange Transfusion and Leukapheresis in Pediatric AML Patients with High Risk of Early Death for Bleeding and Leukostasis

Ursula Creutzig, MD, Claudia Rossig, MD, Michael Dworzak, MD, Arendt von Stackelberg, MD, Wilhelm Woessmann, MD, Jan Stary, Martin Zimmermann, PhD, Dirk Reinhardt, MD

Blood (2015) 126 (23): 3741.

https://doi.org/10.1182/blood.V126.23.3741.3741

Published: 2015

Journal Articles

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Wilhelm Woessmann, MD, Martin Zimmermann, Birgit Burkhardt, Andrea Meinhardt, MD, Christine Rosenbusch, MD, Vera Vaillant, MD, Ilske Oschlies, Wolfram Klapper, MD, Felix Niggli, MD, Andishe Attarbaschi, MD, Georg Mann, MD, Martin Schrappe, MD, Alfred Reiter, MD

Blood (2014) 124 (21): 1738.

https://doi.org/10.1182/blood.V124.21.1738.1738

Published: 2014

Journal Articles

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK –positive anaplastic large-cell lymphoma

Christine Damm-Welk, Lara Mussolin, Martin Zimmermann, Marta Pillon, Wolfram Klapper, Ilske Oschlies, Emanuele S. G. d’Amore, Alfred Reiter, Wilhelm Woessmann, Angelo Rosolen

Blood (2014) 123 (3): 334–337.

https://doi.org/10.1182/blood-2013-09-526202

Published: 2014

Includes: Supplemental data

Journal Articles

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Andre Manfred Willasch, MD, Eva Rettinger, MD, Marion Zabel, MD, Hermann Kreyenberg, PhD, Vida Meyer, Arndt Borkhardt, MD, Markus Metzler, MD, Bernhard Kremens, MD, Brigitte Strahm, MD, Wilhelm Woessmann, MD, Christine Mauz-Koerholz, MD, Bernd Gruhn, Stefan Burdach, MD, Michael H Albert, MD, Paul G. Schlegel, MD, Thomas Klingebiel, MD, Peter Bader

Blood (2013) 122 (21): 411.

https://doi.org/10.1182/blood.V122.21.411.411

Published: 2013

Journal Articles

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

Wolfram Klapper, Markus Kreuz, Christian W. Kohler, Birgit Burkhardt, Monika Szczepanowski, Itziar Salaverria, Michael Hummel, Markus Loeffler, Shoji Pellissery, Wilhelm Woessmann, Carsten Schwänen, Lorenz Trümper, Swen Wessendorf, Rainer Spang, Dirk Hasenclever, Reiner Siebert, for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe

Blood (2012) 119 (8): 1882–1887.

https://doi.org/10.1182/blood-2011-10-388470

Published: 2012

Includes: Supplemental data

Journal Articles

Early Assessment of Minimal Residual Disease (MRD) by Qualitative PCR for NPM-ALK Identifies Patients At Very High Risk of Relapse in Anaplastic Large Cell Lymphoma

Christine Damm-Welk, PhD, Lara Mussolin, PhD, Marta Pillon, MD, Martin Zimmermann, PhD, Alfred Reiter, MD, Wilhelm Woessmann, MD, Angelo Rosolen, MD

Blood (2011) 118 (21): 1565.

https://doi.org/10.1182/blood.V118.21.1565.1565

Published: 2011

Journal Articles

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Eva Rettinger, Andre M. Willasch, Hermann Kreyenberg, Arndt Borkhardt, Wolfgang Holter, Bernhard Kremens, Brigitte Strahm, Wilhelm Woessmann, Christine Mauz-Koerholz, Bernd Gruhn, Stefan Burdach, Michael H. Albert, Paul-Gerhardt Schlegel, Thomas Klingebiel, Peter Bader

Blood (2011) 118 (20): 5681–5688.

https://doi.org/10.1182/blood-2011-04-348805

Published: 2011

Includes: Supplemental data

Journal Articles

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

Kamel Ait-Tahar, Christine Damm-Welk, Birgit Burkhardt, Martin Zimmermann, Wolfram Klapper, Alfred Reiter, Karen Pulford, Wilhelm Woessmann

Blood (2010) 115 (16): 3314–3319.

https://doi.org/10.1182/blood-2009-11-251892

Published: 2010

Includes: Supplemental data

Journal Articles

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Birgit Burkhardt, MD, PhD, Ilske Oschlies, MD, Wolfram Klapper, MD, PhD, Martin Zimmermann, PhD, Andrea Meinhardt, MD, Eva Landmann, MD, Wilhelm Woessmann, MD, PhD, Georg Mann, MD, Felix Niggli, MD, Martin Schrappe, MD, PhD, Alfred Reiter, MD, PhD

Blood (2009) 114 (22): 102.

https://doi.org/10.1182/blood.V114.22.102.102

Published: 2009

Journal Articles

Circulating Antibodies to ALK Inversely Correlat with Relapse Risk and Circulating Tumor Cells in Children and Adolescents with ALK-Positive Anaplastic Large Cell Lymphoma

Karen Pulford, Christine Damm-Welk, Birgit Burkhardt, Martin Zimmerman, Alfred Reiter, Kamel Ait-Tahar, Wilhelm Woessmann

Blood (2008) 112 (11): 2831.

https://doi.org/10.1182/blood.V112.11.2831.2831

Published: 2008

NARROW

Brigatinib Monotherapy in Children with R/R ALK+ ALCL, IMT, or Other Solid Tumors: Updated Results from the Brigaped (ITCC-098) Phase 1 Dose-Escalation Study

Addition of Anti-T-Lymphocyte-Globuline As Graft Versus Host Disease Prophylaxis for Matched Unrelated Donors Equalizes Outcomes with Matched Sibling Donors: Results from the AML SCT-BFM 2007 Trial

Pediatric T-cell lymphoblastic lymphomas but not leukemias harbor TRB :: NOTCH1 fusions with unfavorable outcome

Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance

IL10RA modulates crizotinib sensitivity in NPM1-ALK + anaplastic large cell lymphoma

Progressive or relapsed Burkitt lymphoma or leukemia in children and adolescents after BFM-type first-line therapy

Imatinib +/- Brentuximab Vedotin Induces Sustained Complete Remission in Chemotherapy-Resistant Anaplastic Large Cell Lymphoma Expressing PDGFR

Stem Cell Transplantation for Pediatric Patients with Non-Anaplastic Peripheral T-Cell Lymphoma on Behalf of the EBMT-Pediatric Diseases Working Party

AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-MÃ¼nster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia

The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis

Exchange Transfusion and Leukapheresis in Pediatric AML Patients with High Risk of Early Death for Bleeding and Leukostasis

Relapsed or Refractory Burkitt Lymphoma in Children and Adolescents after BFM-Type First-Line Therapy - a BFM Group Report

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK –positive anaplastic large-cell lymphoma

Clinical Impact Of Post-Transplant Chimerism Monitoring In CD33/34 Bone Marrow Subpopulations and Whole Blood In Pediatric AML: Prospective Comparison Of Highly Sensitive Real Time Sequence Polymorphism PCR Versus Gold-Standard Conventional STR-PCR

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

Early Assessment of Minimal Residual Disease (MRD) by Qualitative PCR for NPM-ALK Identifies Patients At Very High Risk of Relapse in Anaplastic Large Cell Lymphoma

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk

Non-Hodgkin Lymphoma in Adolescents: Experiences in 378 Adolescent NHL Patients Treated According to Pediatric NHL-BFM Protocols.

Circulating Antibodies to ALK Inversely Correlat with Relapse Risk and Circulating Tumor Cells in Children and Adolescents with ALK-Positive Anaplastic Large Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only